Hongfeng Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hongfeng Yang has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Wen Zhang
Department of Laboratory Medicine, School of Medicine Jiangsu University Zhenjiang China
15 shared publications Shixing Yang
Department of Laboratory Medicine, School of Medicine, Jiangsu University
9 shared publicationsShiyin Huang
Department of Laboratory Medicine, School of Medicine, Jiangsu University
8 shared publicationsXiaochun Wang
Department of Laboratory Medicine, School of Medicine, Jiangsu University
8 shared publicationsYue Chen
Department of Laboratory Medicine, School of Medicine, Jiangsu University
8 shared publicationsPing Wu
Department of Laboratory Medicine, School of Medicine, Jiangsu University
7 shared publications
Latest Publications
- Open Access
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0341925
Getah virus non-structural protein 2 inhibits type I interferon production by preventing K63-linked polyubiquitination of IKKε and causing widespread cellular shutoff
Getah virus (GETV) is an emerging mosquito-borne alphavirus that poses a growing threat to animal and public health. However, the molecular mechanisms underlying its pathogenesis and immune evasion remain poorly defined. This study demonstrated that GETV infection suppressed the activation of interferon β (IFN-β) or IFN-stimulated response element after poly(I:C) stimulation. By screening nine viral proteins (non-structural proteins 1–4 [nsP1–4] and C-E3-E2-6K-E1), we discovered that the nsP2 protein of GETV could effectively inhibit the production of IFN-β and IFN-stimulated genes. Subsequently, we discovered that nsP2 disrupted the retinoic acid-inducible gene I-like receptor signaling pathway by causing widespread cellular shutoff and directly targeting inhibitor of kappa-B kinase ε (IKKε). Mechanistically, the inhibitory function of nsP2 is contingent upon the protein’s structural integrity and the presence of proline 717 and nuclear localization signal-related residues. Additionally, we illustrated that nsP2 markedly inhibited TRAF2-induced K63-linked polyubiquitination and phosphorylation of IKKε, which is essential for activating IKKε. Altogether, the present study elucidated a new mechanism in which GETV modulates the host’s antiviral immunity. IMPORTANCE: Getah virus (GETV), a multi-host alphavirus of the Togaviridae family, imposes a significant economic burden on the swine industry by causing fever, diarrhea, reproductive disorders in sows, and elevated mortality in newborn piglets. Here, we reveal that GETV non-structural protein 2 antagonizes interferon β (IFN-β) production through a dual mechanism: it induces broad cellular shutoff and directly interacts with inhibitor of kappa-B kinase ε (IKKε) to prevent its activation. This strategy effectively disrupts type I IFN responses by suppressing antiviral gene expression, such as IKKε, IFN-I, and IFN-stimulated genes, and impairing retinoic acid-inducible gene I-like receptor signaling activation. Our findings not only uncover a novel mechanism of GETV immune evasion but also establish the rationale for novel therapeutic targets, suggesting a new avenue for the treatment and intervention of GETV infection.
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0341925
Open AccessGetah virus non-structural protein 2 inhibits type I interferon production by preventing K63-linked polyubiquitination of IKKε and causing widespread cellular shutoff
Getah virus (GETV) is an emerging mosquito-borne alphavirus that poses a growing threat to animal and public health. However, the molecular mechanisms underlying its pathogenesis and immune evasion remain poorly defined. This study demonstrated that GETV infection suppressed the activation of interferon β (IFN-β) or IFN-stimulated response element after poly(I:C) stimulation. By screening nine viral proteins (non-structural proteins 1–4 [nsP1–4] and C-E3-E2-6K-E1), we discovered that the nsP2 protein of GETV could effectively inhibit the production of IFN-β and IFN-stimulated genes. Subsequently, we discovered that nsP2 disrupted the retinoic acid-inducible gene I-like receptor signaling pathway by causing widespread cellular shutoff and directly targeting inhibitor of kappa-B kinase ε (IKKε). Mechanistically, the inhibitory function of nsP2 is contingent upon the protein’s structural integrity and the presence of proline 717 and nuclear localization signal-related residues. Additionally, we illustrated that nsP2 markedly inhibited TRAF2-induced K63-linked polyubiquitination and phosphorylation of IKKε, which is essential for activating IKKε. Altogether, the present study elucidated a new mechanism in which GETV modulates the host’s antiviral immunity. IMPORTANCE: Getah virus (GETV), a multi-host alphavirus of the Togaviridae family, imposes a significant economic burden on the swine industry by causing fever, diarrhea, reproductive disorders in sows, and elevated mortality in newborn piglets. Here, we reveal that GETV non-structural protein 2 antagonizes interferon β (IFN-β) production through a dual mechanism: it induces broad cellular shutoff and directly interacts with inhibitor of kappa-B kinase ε (IKKε) to prevent its activation. This strategy effectively disrupts type I IFN responses by suppressing antiviral gene expression, such as IKKε, IFN-I, and IFN-stimulated genes, and impairing retinoic acid-inducible gene I-like receptor signaling activation. Our findings not only uncover a novel mechanism of GETV immune evasion but also establish the rationale for novel therapeutic targets, suggesting a new avenue for the treatment and intervention of GETV infection.
- Open Access
- 3 July 2026
- Published by Springer Nature in Virology Journal
- Vol. 23 (1)
Viral metagenomic analysis of the blood virome in patients with multiple autoimmune diseases
The online version contains supplementary material available at 10.1186/s12985-026-03172-8.
- 3 July 2026
- Published by Springer Nature in Virology Journal
- Vol. 23 (1)
Open AccessViral metagenomic analysis of the blood virome in patients with multiple autoimmune diseases
The online version contains supplementary material available at 10.1186/s12985-026-03172-8.
- Open Access
- 30 June 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (7) , e0084825
Comparative analysis of gut viromes in four penguin species reveals diverse novel viruses and host-associated differences
Penguins, as distinctive marine birds, play important roles in polar and sub-Antarctic ecosystems, yet the diversity and species-specific distribution of their gut viromes remain insufficiently understood. Here, we used viral metagenomics to characterize the cloacal viromes of four penguin species— Spheniscus humboldti ( S. humboldti ), Pygoscelis papua ( P. papua ), Pygoscelis adeliae ( P. adeliae ), and Aptenodytes forsteri ( A. forsteri )—collected at Chimelong Ocean Kingdom. A total of 219 viral sequences representing potentially novel lineages were identified, with more than 94% sharing S. humboldti , Microviridae were enriched in P. papua , Caliciviridae accounted for a substantial proportion in A. forsteri , and P. adeliae displayed the greatest overall virome diversity. Multiple-virus co-detections, particularly involving Parvoviridae, were frequent in S. humboldti . Phylogenetic analyses showed that many penguin-associated viruses clustered with viruses infecting other avian and fish hosts, suggesting possible dietary or environmental origins of some detected viral sequences. These findings expand current knowledge of penguin gut virome diversity and host-associated differences and provide a valuable foundation for evaluating the ecological roles, health implications, and transmission risks of penguin-associated viruses. IMPORTANCE: This study uncovers significant diversity in the gut viromes of four penguin species, revealing over 219 viral sequences representing potentially novel lineages, many of which showed host-associated distribution patterns. Using viral metagenomics, we identified notable interspecies differences, with Parvoviridae predominating in Spheniscus humboldti and Microviridae being enriched in Pygoscelis papua. These findings highlight the complexity of viral community structures in penguins, including frequent viral co-detections, which could impact host health and ecological adaptation. Additionally, novel bacteriophage communities were identified, emphasizing their potential role in shaping the gut microbiome and influencing viral dynamics. This work provides new insights into viral diversity in wildlife and lays the groundwork for future studies on viral transmission risks and ecological conservation.
- 30 June 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (7) , e0084825
Open AccessComparative analysis of gut viromes in four penguin species reveals diverse novel viruses and host-associated differences
Penguins, as distinctive marine birds, play important roles in polar and sub-Antarctic ecosystems, yet the diversity and species-specific distribution of their gut viromes remain insufficiently understood. Here, we used viral metagenomics to characterize the cloacal viromes of four penguin species— Spheniscus humboldti ( S. humboldti ), Pygoscelis papua ( P. papua ), Pygoscelis adeliae ( P. adeliae ), and Aptenodytes forsteri ( A. forsteri )—collected at Chimelong Ocean Kingdom. A total of 219 viral sequences representing potentially novel lineages were identified, with more than 94% sharing S. humboldti , Microviridae were enriched in P. papua , Caliciviridae accounted for a substantial proportion in A. forsteri , and P. adeliae displayed the greatest overall virome diversity. Multiple-virus co-detections, particularly involving Parvoviridae, were frequent in S. humboldti . Phylogenetic analyses showed that many penguin-associated viruses clustered with viruses infecting other avian and fish hosts, suggesting possible dietary or environmental origins of some detected viral sequences. These findings expand current knowledge of penguin gut virome diversity and host-associated differences and provide a valuable foundation for evaluating the ecological roles, health implications, and transmission risks of penguin-associated viruses. IMPORTANCE: This study uncovers significant diversity in the gut viromes of four penguin species, revealing over 219 viral sequences representing potentially novel lineages, many of which showed host-associated distribution patterns. Using viral metagenomics, we identified notable interspecies differences, with Parvoviridae predominating in Spheniscus humboldti and Microviridae being enriched in Pygoscelis papua. These findings highlight the complexity of viral community structures in penguins, including frequent viral co-detections, which could impact host health and ecological adaptation. Additionally, novel bacteriophage communities were identified, emphasizing their potential role in shaping the gut microbiome and influencing viral dynamics. This work provides new insights into viral diversity in wildlife and lays the groundwork for future studies on viral transmission risks and ecological conservation.
- Open Access
- 16 April 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Mechanisms biomarkers and therapeutic strategies of human endogenous retroviruses in cancer
Human endogenous retroviruses (HERVs), constituting roughly 8% of the human genome, have undergone a profound conceptual evolution from dismissed genomic “fossils” to critical, dualistic regulators in cancer biology. Their pathognomonic reactivation across malignancies orchestrates tumorigenesis through three interconnected molecular axes: (1) genomic destabilization via LTR-mediated insertional mutagenesis, disrupting key loci such as TP53 and MYC ; (2) immune checkpoint subversion, driven by HERV-K envelope glycoprotein-induced PD-L1 upregulation (2.3-fold; p < 0.01); and (3) chronic inflammatory signaling triggered by double-stranded RNA (dsRNA) activation of innate immune pathways (TLR3/MDA5/NLRP3). This foundational mechanistic insight is accelerating clinical translation. Diagnostic advances now feature HERV-K Env-targeted liquid biopsies achieving 92% specificity (AUC = 0.94) for early-stage tumors and artificial intelligence (AI)-enhanced platforms (e.g., DeepHERV, AUC = 0.91) that resolve complex HERV expression landscapes. Therapeutically, an emerging pipeline of strategies is rapidly advancing, from initial first-in-human clinical trials (NCT05687903, NCT05554866) of HERV-directed monoclonal antibodies and vaccines to the highly promising preclinical efficacy demonstrated by HERV-K-specific chimeric antigen receptor (CAR) T-cells (> 70% tumor regression) and locus-precise CRISPR/Cas9 epigenetic silencing. However, clinical translation is complicated by persistent challenges, including intratumoral HERV heterogeneity, a lack of assay standardization (as evidenced by 60% primer discordance), and the fundamental ethical and therapeutic requirement for specificity—that is, precise discrimination between pathogenic HERVs and their essential physiological counterparts. A convergent translational framework—leveraging international consortia for biomarker validation, machine learning for patient stratification, and engineered tumor-selective delivery platforms—is now positioned to harness this novel target class and redefine the next era of precision oncology.
- 16 April 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Open AccessMechanisms biomarkers and therapeutic strategies of human endogenous retroviruses in cancer
Human endogenous retroviruses (HERVs), constituting roughly 8% of the human genome, have undergone a profound conceptual evolution from dismissed genomic “fossils” to critical, dualistic regulators in cancer biology. Their pathognomonic reactivation across malignancies orchestrates tumorigenesis through three interconnected molecular axes: (1) genomic destabilization via LTR-mediated insertional mutagenesis, disrupting key loci such as TP53 and MYC ; (2) immune checkpoint subversion, driven by HERV-K envelope glycoprotein-induced PD-L1 upregulation (2.3-fold; p < 0.01); and (3) chronic inflammatory signaling triggered by double-stranded RNA (dsRNA) activation of innate immune pathways (TLR3/MDA5/NLRP3). This foundational mechanistic insight is accelerating clinical translation. Diagnostic advances now feature HERV-K Env-targeted liquid biopsies achieving 92% specificity (AUC = 0.94) for early-stage tumors and artificial intelligence (AI)-enhanced platforms (e.g., DeepHERV, AUC = 0.91) that resolve complex HERV expression landscapes. Therapeutically, an emerging pipeline of strategies is rapidly advancing, from initial first-in-human clinical trials (NCT05687903, NCT05554866) of HERV-directed monoclonal antibodies and vaccines to the highly promising preclinical efficacy demonstrated by HERV-K-specific chimeric antigen receptor (CAR) T-cells (> 70% tumor regression) and locus-precise CRISPR/Cas9 epigenetic silencing. However, clinical translation is complicated by persistent challenges, including intratumoral HERV heterogeneity, a lack of assay standardization (as evidenced by 60% primer discordance), and the fundamental ethical and therapeutic requirement for specificity—that is, precise discrimination between pathogenic HERVs and their essential physiological counterparts. A convergent translational framework—leveraging international consortia for biomarker validation, machine learning for patient stratification, and engineered tumor-selective delivery platforms—is now positioned to harness this novel target class and redefine the next era of precision oncology.
- Open Access
- 31 March 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Systemic remodeling of the multi-organ virome following Echinococcus infection in mice
The interaction between parasitic infection and the host virome represents a frontier issue in microbial ecology, yet how Echinococcus infection affects th
- 31 March 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Open AccessSystemic remodeling of the multi-organ virome following Echinococcus infection in mice
The interaction between parasitic infection and the host virome represents a frontier issue in microbial ecology, yet how Echinococcus infection affects th
- Open Access
- 13 March 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Viromic profiling of amniotic fluid reveals distinct viral communities associated with maternal health status
Amniotic fluid is a critical compartment in pregnancy; however, its virome remains poorly characterized, and potential associations with maternal–fetal health are largely unexplored. This study aimed to comprehensively profile the human amniotic fluid virome and explore its association with maternal health status during pregnancy. We performed viral metagenomic sequencing of 515 amniotic fluid samples from 515 pregnant women in Changzhou, China, including healthy pregnancies (n = 275) and pregnancies with complications (n = 240). Viral sequences were identified using a bioinformatics pipeline, and phylogenetic analyses were used to assess genetic relationships. We identified diverse viral sequences, including members of viral families such as Anelloviridae and Paramyxoviridae. BLAST-based nucleotide comparisons showed high nucleotide identity to previously reported viruses, indicating that many detected sequences are closely related to known viruses. Phylogenetic analyses further supported their placement within established viral taxa. Community-level analyses indicated differences in virome composition profiles between the healthy control and disease groups. Our findings describe a previously undercharacterized virome in human amniotic fluid. This study establishes a basis for future investigations into the origins and potential associations of these viral signatures with pregnancy health, highlighting the importance of assessing their clinical relevance for both maternal and neonatal outcomes. Because metagenomic sequencing detects viral nucleic acids, these findings do not establish viral infectivity or causality. The online version contains supplementary material available at 10.1186/s12884-026-08933-5.
- 13 March 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessViromic profiling of amniotic fluid reveals distinct viral communities associated with maternal health status
Amniotic fluid is a critical compartment in pregnancy; however, its virome remains poorly characterized, and potential associations with maternal–fetal health are largely unexplored. This study aimed to comprehensively profile the human amniotic fluid virome and explore its association with maternal health status during pregnancy. We performed viral metagenomic sequencing of 515 amniotic fluid samples from 515 pregnant women in Changzhou, China, including healthy pregnancies (n = 275) and pregnancies with complications (n = 240). Viral sequences were identified using a bioinformatics pipeline, and phylogenetic analyses were used to assess genetic relationships. We identified diverse viral sequences, including members of viral families such as Anelloviridae and Paramyxoviridae. BLAST-based nucleotide comparisons showed high nucleotide identity to previously reported viruses, indicating that many detected sequences are closely related to known viruses. Phylogenetic analyses further supported their placement within established viral taxa. Community-level analyses indicated differences in virome composition profiles between the healthy control and disease groups. Our findings describe a previously undercharacterized virome in human amniotic fluid. This study establishes a basis for future investigations into the origins and potential associations of these viral signatures with pregnancy health, highlighting the importance of assessing their clinical relevance for both maternal and neonatal outcomes. Because metagenomic sequencing detects viral nucleic acids, these findings do not establish viral infectivity or causality. The online version contains supplementary material available at 10.1186/s12884-026-08933-5.
- Open Access
- 3 March 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (3) , e0332725
A novel parvovirus circulating in canine populations and sporadically detected in human oropharyngeal samples
Most human pathogens, while originating from animals, have crossed species barriers to infect humans, often leading to outbreaks of new infectious diseases. Despite significant efforts, the mechanisms, timing, and locations of these emerging diseases remain largely uncertain. Here, using a viral metagenomic approach, we discovered a novel canine-associated parvovirus in human oropharyngeal secretions. Molecular screening revealed the presence of this parvovirus in different canine tissues, including 24 of 108 pharyngeal lymph node samples. Further molecular investigation showed that the virus was detected in the oropharyngeal secretions of pet dogs and in human samples that were not linked to these animals. This parvovirus was therefore named human-canine associated parvovirus 1 (HCAPV-1). Nine complete genomes of HCAPV-1 were acquired through next-generation sequencing, combining Sanger sequencing. Genomic and phylogenetic analyses indicate that these nine strains of HCAPV-1 belong to the genus Protoparvovirus and form a distinct clade, with their closest relatives being newlaviruses from foxes. Amino acid substitutions have been characterized in the capsid proteins of the variants of HCAPV-1, which potentially alter their infection patterns. Potential genomic recombination was also observed in HCAPV-1. Taken together, our findings reveal the presence of a novel parvovirus in both canine and human samples, highlighting the need to investigate its host range and transmission dynamics. IMPORTANCE: This study identified a novel parvovirus, human-canine associated parvovirus 1 (HCAPV-1), which was detected in human oropharyngeal secretions and various canine tissues, suggesting that its host range may extend beyond a single species. Phylogenetic analysis revealed that HCAPV-1 forms a distinct clade within the genus Protoparvovirus , closely related to newlaviruses from foxes. Amino acid substitutions observed in the capsid proteins of HCAPV-1 variants indicate genetic divergence, warranting further investigation into their potential implications for host interactions. Recombination events may have contributed to its emergence. This finding highlights the importance of continued surveillance in settings where humans and companion animals coexist and underscores the need for further research to clarify the ecological and host-range characteristics of such viruses.
- 3 March 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (3) , e0332725
Open AccessA novel parvovirus circulating in canine populations and sporadically detected in human oropharyngeal samples
Most human pathogens, while originating from animals, have crossed species barriers to infect humans, often leading to outbreaks of new infectious diseases. Despite significant efforts, the mechanisms, timing, and locations of these emerging diseases remain largely uncertain. Here, using a viral metagenomic approach, we discovered a novel canine-associated parvovirus in human oropharyngeal secretions. Molecular screening revealed the presence of this parvovirus in different canine tissues, including 24 of 108 pharyngeal lymph node samples. Further molecular investigation showed that the virus was detected in the oropharyngeal secretions of pet dogs and in human samples that were not linked to these animals. This parvovirus was therefore named human-canine associated parvovirus 1 (HCAPV-1). Nine complete genomes of HCAPV-1 were acquired through next-generation sequencing, combining Sanger sequencing. Genomic and phylogenetic analyses indicate that these nine strains of HCAPV-1 belong to the genus Protoparvovirus and form a distinct clade, with their closest relatives being newlaviruses from foxes. Amino acid substitutions have been characterized in the capsid proteins of the variants of HCAPV-1, which potentially alter their infection patterns. Potential genomic recombination was also observed in HCAPV-1. Taken together, our findings reveal the presence of a novel parvovirus in both canine and human samples, highlighting the need to investigate its host range and transmission dynamics. IMPORTANCE: This study identified a novel parvovirus, human-canine associated parvovirus 1 (HCAPV-1), which was detected in human oropharyngeal secretions and various canine tissues, suggesting that its host range may extend beyond a single species. Phylogenetic analysis revealed that HCAPV-1 forms a distinct clade within the genus Protoparvovirus , closely related to newlaviruses from foxes. Amino acid substitutions observed in the capsid proteins of HCAPV-1 variants indicate genetic divergence, warranting further investigation into their potential implications for host interactions. Recombination events may have contributed to its emergence. This finding highlights the importance of continued surveillance in settings where humans and companion animals coexist and underscores the need for further research to clarify the ecological and host-range characteristics of such viruses.
- Open Access
- 25 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1761545
Group-based trajectory modeling of platelet dynamics in sepsis: from phenotypic identification to the exploration of prognostic mediators
Sepsis continues to impose a substantial global burden, with persistently high rates of hospitalization and mortality. A major challenge in advancing sepsis therapeutics lies in its inherent clinical and biological heterogeneity. Recent research has increasingly shifted from static biomarker assessment toward the identification of dynamic trajectory subtypes to better capture this heterogeneity. Objective: This study aims to characterize the temporal patterns of platelet count changes during the first three days after admission among 280 sepsis patients using group-based trajectory modeling (GBTM), assess their association with clinical outcomes, and explore potential mediating pathways. Methods: We retrospectively analyzed data from 280 sepsis patients admitted to the Department of Critical Care Medicine at Jiangsu University Affiliated People's Hospital between September 2022 and December 2024. Baseline demographics, clinical characteristics, and serial platelet counts were collected. Missing data were addressed using multiple imputation techniques. GBTM was applied to identify distinct trajectory patterns of platelet counts. The association between each trajectory and 28-day all-cause mortality was evaluated using multivariable Cox proportional hazards regression models. Additionally, mediation analysis was performed to investigate potential mechanisms underlying these associations. Results: GBTM revealed three distinct platelet count trajectories: persistent low level (71.79%), high-level decline (20.00%), and rebound rise (8.21%). Patients in the persistent low-level group exhibited significantly higher 28-day all-cause mortality compared to the other two groups (71.63% vs. 55.36% vs. 13.04%, p < 0.05) and had the shortest median survival time. After adjusting for key confounders, Cox regression showed that, relative to the persistent low-level group, the high-level decline group had a 42% lower risk of death ( HR = 0.58, 95% CI: 0.36–0.92, p = 0.02), while the rebound rise group demonstrated an 93% reduction in mortality risk ( HR = 0.07, 95% CI: 0.02–0.26, p < 0.001). Mediation analysis indicated that the effect of platelet trajectories on 28-day mortality may be partially mediated through changes in Sequential Organ Failure Assessment (SOFA) score and log-transformed APTT. Conclusion: Dynamic modeling of platelet count trajectories enables effective identification of clinically meaningful subphenotypes in sepsis patients, offering a robust framework for prognosis prediction. This approach supports refined risk stratification and personalized management strategies, thereby providing novel insights into the pathophysiology and clinical care of sepsis.
- 25 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1761545
Open AccessGroup-based trajectory modeling of platelet dynamics in sepsis: from phenotypic identification to the exploration of prognostic mediators
Sepsis continues to impose a substantial global burden, with persistently high rates of hospitalization and mortality. A major challenge in advancing sepsis therapeutics lies in its inherent clinical and biological heterogeneity. Recent research has increasingly shifted from static biomarker assessment toward the identification of dynamic trajectory subtypes to better capture this heterogeneity. Objective: This study aims to characterize the temporal patterns of platelet count changes during the first three days after admission among 280 sepsis patients using group-based trajectory modeling (GBTM), assess their association with clinical outcomes, and explore potential mediating pathways. Methods: We retrospectively analyzed data from 280 sepsis patients admitted to the Department of Critical Care Medicine at Jiangsu University Affiliated People's Hospital between September 2022 and December 2024. Baseline demographics, clinical characteristics, and serial platelet counts were collected. Missing data were addressed using multiple imputation techniques. GBTM was applied to identify distinct trajectory patterns of platelet counts. The association between each trajectory and 28-day all-cause mortality was evaluated using multivariable Cox proportional hazards regression models. Additionally, mediation analysis was performed to investigate potential mechanisms underlying these associations. Results: GBTM revealed three distinct platelet count trajectories: persistent low level (71.79%), high-level decline (20.00%), and rebound rise (8.21%). Patients in the persistent low-level group exhibited significantly higher 28-day all-cause mortality compared to the other two groups (71.63% vs. 55.36% vs. 13.04%, p < 0.05) and had the shortest median survival time. After adjusting for key confounders, Cox regression showed that, relative to the persistent low-level group, the high-level decline group had a 42% lower risk of death ( HR = 0.58, 95% CI: 0.36–0.92, p = 0.02), while the rebound rise group demonstrated an 93% reduction in mortality risk ( HR = 0.07, 95% CI: 0.02–0.26, p < 0.001). Mediation analysis indicated that the effect of platelet trajectories on 28-day mortality may be partially mediated through changes in Sequential Organ Failure Assessment (SOFA) score and log-transformed APTT. Conclusion: Dynamic modeling of platelet count trajectories enables effective identification of clinically meaningful subphenotypes in sepsis patients, offering a robust framework for prognosis prediction. This approach supports refined risk stratification and personalized management strategies, thereby providing novel insights into the pathophysiology and clinical care of sepsis.
- 1 January 2026
- Vol. 38 (1) , 50-55
[Association between right ventricular function and short-term death risk in patients with sepsis].
To evaluate the right ventricular function in patients with sepsis and to analyze the association between right ventricular dysfunction and 30-day mortality. A retrospective cohort study was conducted. The clinical data from 196 adult patients with sepsis admitted to the department of critical care medicine of the Affiliated People's Hospital of Jiangsu University from January 2020 to December 2023 were collected, including age, gender, mean arterial pressure (MAP), oxygenation index (PaO2/FiO2), heart rate (HR), urine output, continuous renal replacement therapy (CRRT), presence of acute renal failure, Acute Physiology And Chronic Health Evaluation II (APACHE II) score, Sequential Organ Failure Assessment (SOFA) score, Elixhauser comorbidity index (ECI) score, blood lactic acid (Lac), fluid resuscitation volume, vasoactive drug dose, mechanical ventilation status, echocardiographic parameters within 24 hours after admission, and 30-day outcomes. Demographic, clinical, and echocardiographic features were compared between survivors and non-survivors. The prevalence and death risk of ventricular dysfunction subtypes in patients with sepsis were analyzed. Multivariate Logistic regression analysis was used to identify independent risk factors for short-term death risk. Among 196 patients with sepsis, 157 survived for 30 days and 39 died. Compared with the survival group, the patients in the non-survival group had less urine output, a higher proportion of patients receiving CRRT, higher APACHE II score, higher Lac, higher doses of vasoactive drugs, and a higher proportion of requiring mechanical ventilation. Echocardiography showed that the patients in the non-survival group had lower tricuspid annular peak systolic excursion (TAPSE), right ventricular fractional area change, and left ventricular ejection fraction (LVEF) as compared with those in the survival group [TAPSE (mm): 16.0±3.6 vs. 19.3±4.4, right ventricular fractional area change: (30.23±8.14)% vs. (33.69±7.81)%, LVEF: 0.575±0.129 vs. 0.637±0.069, all P2): 15.75±4.45 vs. 14.27±3.39, left ventricular E/E' ratio: 9.18±4.43 vs. 7.74±3.12, both P-1×min-1): 1.1 (0.2, 2.1) vs. 0.7 (0.2, 2.0), ratio of requiring mechanical ventilation: 18.8% (18/96) vs. 15.0% (15/100), 30-day mortality: 40.6% (39/96) vs. 21.0% (21/100), all P<0.05]. Multivariate Logistic regression analysis identified CRRT [odds ratio (OR)=2.43, 95% confidence interval (95%CI) was 0.25-0.64], higher APACHE II score (OR=1.35, 95%CI was 1.21-1.65), higher Lac (OR=13.44, 95%CI was 6.15-25.35), higher vasoactive drug dose (OR=65.45, 95%CI was 19.88-195.83), mechanical ventilation (OR=92.45, 95%CI was 34.67-369.45), right ventricular dysfunction (OR=2.34, 95%CI was 1.21-3.78), and left ventricular diastolic dysfunction (OR=2.35, 95%CI was 1.09-5.18) as independent risk factors of 30-day death in patients with sepsis (all P<0.05). Right ventricular dysfunction is common in patients with early sepsis and serves as an independent risk factor for 30-day death.
- 1 January 2026
- Vol. 38 (1) , 50-55
[Association between right ventricular function and short-term death risk in patients with sepsis].
To evaluate the right ventricular function in patients with sepsis and to analyze the association between right ventricular dysfunction and 30-day mortality. A retrospective cohort study was conducted. The clinical data from 196 adult patients with sepsis admitted to the department of critical care medicine of the Affiliated People's Hospital of Jiangsu University from January 2020 to December 2023 were collected, including age, gender, mean arterial pressure (MAP), oxygenation index (PaO2/FiO2), heart rate (HR), urine output, continuous renal replacement therapy (CRRT), presence of acute renal failure, Acute Physiology And Chronic Health Evaluation II (APACHE II) score, Sequential Organ Failure Assessment (SOFA) score, Elixhauser comorbidity index (ECI) score, blood lactic acid (Lac), fluid resuscitation volume, vasoactive drug dose, mechanical ventilation status, echocardiographic parameters within 24 hours after admission, and 30-day outcomes. Demographic, clinical, and echocardiographic features were compared between survivors and non-survivors. The prevalence and death risk of ventricular dysfunction subtypes in patients with sepsis were analyzed. Multivariate Logistic regression analysis was used to identify independent risk factors for short-term death risk. Among 196 patients with sepsis, 157 survived for 30 days and 39 died. Compared with the survival group, the patients in the non-survival group had less urine output, a higher proportion of patients receiving CRRT, higher APACHE II score, higher Lac, higher doses of vasoactive drugs, and a higher proportion of requiring mechanical ventilation. Echocardiography showed that the patients in the non-survival group had lower tricuspid annular peak systolic excursion (TAPSE), right ventricular fractional area change, and left ventricular ejection fraction (LVEF) as compared with those in the survival group [TAPSE (mm): 16.0±3.6 vs. 19.3±4.4, right ventricular fractional area change: (30.23±8.14)% vs. (33.69±7.81)%, LVEF: 0.575±0.129 vs. 0.637±0.069, all P2): 15.75±4.45 vs. 14.27±3.39, left ventricular E/E' ratio: 9.18±4.43 vs. 7.74±3.12, both P-1×min-1): 1.1 (0.2, 2.1) vs. 0.7 (0.2, 2.0), ratio of requiring mechanical ventilation: 18.8% (18/96) vs. 15.0% (15/100), 30-day mortality: 40.6% (39/96) vs. 21.0% (21/100), all P<0.05]. Multivariate Logistic regression analysis identified CRRT [odds ratio (OR)=2.43, 95% confidence interval (95%CI) was 0.25-0.64], higher APACHE II score (OR=1.35, 95%CI was 1.21-1.65), higher Lac (OR=13.44, 95%CI was 6.15-25.35), higher vasoactive drug dose (OR=65.45, 95%CI was 19.88-195.83), mechanical ventilation (OR=92.45, 95%CI was 34.67-369.45), right ventricular dysfunction (OR=2.34, 95%CI was 1.21-3.78), and left ventricular diastolic dysfunction (OR=2.35, 95%CI was 1.09-5.18) as independent risk factors of 30-day death in patients with sepsis (all P<0.05). Right ventricular dysfunction is common in patients with early sepsis and serves as an independent risk factor for 30-day death.